ArticleThe oncologist2015

Cost-Effectiveness of a Biopsy-Based 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate Cancer.

Joshua A Roth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.